Back to search
FDAFDA · Food and drugs·Recall number Z-2252-2014

Philips IntelliSpace PACS 4.4 image management systems performs digital image processing, measurement and communication and storage.

Published August 27, 2014 · Recall initiated: July 24, 2014

Summary

FDA records medical device Class II recall Z-2252-2014, published August 27, 2014 and initiated July 24, 2014. Recalling firm: Philips Healthcare Informatics, Inc.; Status: Terminated; Reported quantity: 109 units; Lot: IntelliSpace 4.4. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A problem was detected in the Philips IntelliSpace PAC 4.4 software where if patient information is changed in the DICOM header and the study is exported before the image is updated in the PACS, the unchanged data may export causing the potential for diagnosis on incomplete data.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Philips Healthcare Informatics, Inc.
Distributor
US and Australia, Belgium, Canada, Egypt, France, Germany, Netherlands, Oman, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom.
Lot
IntelliSpace 4.4
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Philips IntelliSpace PACS 4.4 image management systems performs digital image processing, measurement and communication and storage. recalled?

Yes. FDA published recall Z-2252-2014 on August 27, 2014. Reported hazard: A problem was detected in the Philips IntelliSpace PAC 4.4 software where if patient information is changed in the DICOM header and the study is exported before the image is updated in the PACS, the unchanged data may export causing the potential for diagnosis on incomplete data.

What should I do if I have this product?

Voluntary: Firm initiated · Letter